Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
DGAP-News: Nordex Group achieves order intake of 7.95 GW in fiscal year 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24063/Nordex_Logo.svg.png
DGAP-News: Nordex Group achieves order intake of 7.95 GW in fiscal year 2021
DGAP-News: Nordex Group achieves order intake of 7.95 GW in fiscal year 2021
DGAP-News: Biotest AG: Biotest combats climate change through CO2-neutral production: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest combats climate change through CO2-neutral production
DGAP-News: Biotest AG: Biotest combats climate change through CO2-neutral production
DGAP-News: AUTO1 Group SE: Q4 2021 Unit Sales and Purchases:
DGAP-News: AUTO1 Group SE: Q4 2021 Unit Sales and Purchases
DGAP-News: AUTO1 Group SE: Q4 2021 Unit Sales and Purchases
COVID-19 Crisis Supercharges Australia’s Digital Push as Enterprises Seek Competitive Advantage: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
COVID-19 Crisis Supercharges Australia’s Digital Push as Enterprises Seek Competitive Advantage


The COVID-19 pandemic has supercharged the ongoing digital transformations of Australian companies, according to a new research report published today by Information Services Group (ISG) (Nasdaq: I

Startek Forms Special Committee in Response to Preliminary Non-Binding Acquisition Proposal by CSP Management Limited: https://mms.businesswire.com/media/20210317005065/en/865538/5/STARTEK_logo.jpg
Startek Forms Special Committee in Response to Preliminary Non-Binding Acquisition Proposal by CSP Management Limited


The board of directors of Startek, Inc. (NYSE: SRT) has formed a special committee of independent directors that is authorized, among other things, to evaluate the non-binding proposal, dated

Nordson Corporation Announces Segment Leadership Transition: https://mms.businesswire.com/media/20191120005506/en/198821/5/Nordson_large.jpg
Nordson Corporation Announces Segment Leadership Transition


Nordson Corporation (Nasdaq: NDSN) announced today that Greg Merk, executive vice president and Industrial Precision Solutions (IPS) segment leader, will be leaving the Company for new

Arista Networks to Announce Q4 2021 Financial Results on Monday, February 14th 2022: https://mms.businesswire.com/media/20210406005937/en/336704/5/Arista_Logo_Transparent_Blue.jpg
Arista Networks to Announce Q4 2021 Financial Results on Monday, February 14th 2022


Arista Networks, Inc. (NYSE:ANET) will release its financial results for the quarter ended December 31st, 2021 after U.S. markets close on Monday, February 14th, 2022. The results will be included

Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million


Regulatory News:



Median Technologies (ALMDT:PA) today announces its business activity indicators for the full year 2021. In 2021, the company’s business continued to grow at a rapid pace.

MaaT Pharma Provides Business Objectives and Expected Milestones for 2022: https://mms.businesswire.com/media/20211211005036/en/729326/5/Nov_2018_new_version_MaaT_Pharma_logo.jpg
MaaT Pharma Provides Business Objectives and Expected Milestones for 2022


Regulatory News:



MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving

DGAP-News: alstria office REIT-AG: Strong leasing results in Ratingen and Essen: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23691/Alstria-office-REIT-Logo.svg.png
DGAP-News: alstria office REIT-AG: Strong leasing results in Ratingen and Essen
DGAP-News: alstria office REIT-AG: Strong leasing results in Ratingen and Essen
Brazilian Firms Act on Digital Transformation Plans in Response to Pandemic Disruptions: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Brazilian Firms Act on Digital Transformation Plans in Response to Pandemic Disruptions


Digital transformation by Brazilian companies has rapidly advanced from concept to execution in recent years, especially as enterprises coped with the effects of the COVID-19 pandemic, according to

ImmunoPrecise Antibodies Announces Grant of Stock Options: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg
ImmunoPrecise Antibodies Announces Grant of Stock Options


IMMUNOPRECISE ANTIBODIES LTD. (“IPA” or the “Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that on January 13, 2022 its board of

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call: https://mms.businesswire.com/media/20210412005210/en/1052735/5/LOGO_ARLP.jpg
Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call


Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its fourth quarter 2021 financial results before the market opens on Monday, January 31, 2022. Alliance management will discuss these

DGAP-News: GEA Group Aktiengesellschaft:  A capital market information: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23714/375px-GEA_Group_2010_logo.svg.png
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry : https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
DGAP-News: CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
DGAP-News: CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
EQS-News: Nordea Bank Abp: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
EQS-News: Nordea Bank Abp: Transaction in Own Shares
EQS-News: Nordea Bank Abp: Transaction in Own Shares
Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss


Regulatory News:



Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

Lomiko Updates Private Placement: https://mms.businesswire.com/media/20210312005102/en/864833/5/LomikoLogo%28horizontal-colour%29.jpg
Lomiko Updates Private Placement


Further to the press release dated January 7, 2022, Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”), subject to the approval of the TSX Venture Exchange for a non-brokered

EPR Properties Announces Tax Status of 2021 Distributions: https://mms.businesswire.com/media/20191216005756/en/351563/5/epr_hor_tag_color_pos_jpg.jpg
EPR Properties Announces Tax Status of 2021 Distributions


EPR Properties (NYSE: EPR) today announced the 2021 year-end tax reporting information for 2021 distributions made to shareholders. Shareholders are encouraged to consult with their personal tax

 Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual): https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg
 Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual)


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the TD Securities Global Mining

Essex Reports Characteristics of 2021 Dividends: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg
Essex Reports Characteristics of 2021 Dividends


Essex Property Trust, Inc. (NYSE:ESS) announced today the income tax treatment for its 2021 distributions to shareholders. The 2021 distribution characteristics are as follows:



Common Stock –

U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis


Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for

ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022: https://mms.businesswire.com/media/20200121005937/en/37691/5/ADTRAN_high-res.jpg
ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022


ADTRAN, Inc. (NASDAQ: ADTN) announced today that the Company will release its financial results for the fourth quarter 2021 after market close on Wednesday, February 2, 2022. The Company will